SNO Meeting 22 Nov - Drug Efficacy Presntation, page-4

Yes thanks R&P …"clinical response to GDC 0084 " and our drug having been chosen from the hundreds of other drugs in Clinical Trials.

Biomarkers are the basis for FDA approvals and everything else in promoting drug development. It would seem a dream situation - for apparently an award for imaging studies on our drug....from a person of this standing.

The CEO did not mention it today, I think because it must serve as a giveaway as to the results of GDC 0084 in this trial.....however its out in the open now and surely market sensitive.

That is my thinking - I am looking for another explanation, or reason for being overly optimistic, but it would seem extremely likely Dr Elliningson has used his skills to find response here with our drug. …. this really helps to confirm the likely and confidence in registration studies.